Literature DB >> 11247674

Molecular cloning of a novel member of the GLUT family of transporters, SLC2a10 (GLUT10), localized on chromosome 20q13.1: a candidate gene for NIDDM susceptibility.

A J McVie-Wylie1, D R Lamson, Y T Chen.   

Abstract

Non-insulin-dependent diabetes mellitus (NIDDM) is a multifactoral disease with both environmental and genetics causes. Genome-wide screening procedures have identified several susceptibility loci for NIDDM within the human genome. We describe the cloning of a putative sugar transporter that has been localized to human chromosome 20q12-q13.1, one of the genomic loci associated with NIDDM. Because of the strong resemblance of this novel protein to members of the mammalian facilitative glucose transporter family (GLUT), we refer to the protein as GLUT10 (HGMW-approved gene symbol SLC2A10). GLUT10 contains 541 amino acids with several glucose transporter sequence motifs and amino acids essential for glucose transport function. In addition, secondary structure analysis of GLUT10 predicts 12 putative transmembrane domains, a hallmark structure of the GLUT family. The tissue distribution of GLUT10 was determined by Northern analysis, which revealed highest levels of expression in the liver and pancreas. From these data, we believe that the chromosomal localization, tissue distribution, and predicted function make GLUT10 an excellent candidate for a susceptibility gene involved in NIDDM. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11247674     DOI: 10.1006/geno.2000.6457

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  37 in total

1.  Gene regulation of UDP-galactose synthesis and transport: potential rate-limiting processes in initiation of milk production in humans.

Authors:  Mahmoud A Mohammad; Darryl L Hadsell; Morey W Haymond
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-05-29       Impact factor: 4.310

2.  Elevation of transcription factor Islet-1 levels in vivo increases β-cell function but not β-cell mass.

Authors:  Jingxuan Liu; Erik R Walp; Catherine Lee May
Journal:  Islets       Date:  2012-05-01       Impact factor: 2.694

Review 3.  Genetics of gestational diabetes mellitus and type 2 diabetes.

Authors:  Richard M Watanabe; Mary Helen Black; Anny H Xiang; Hooman Allayee; Jean M Lawrence; Thomas A Buchanan
Journal:  Diabetes Care       Date:  2007-07       Impact factor: 19.112

Review 4.  Inherited epithelial transporter disorders--an overview.

Authors:  M J Bergeron; A Simonin; M Bürzle; M A Hediger
Journal:  J Inherit Metab Dis       Date:  2008-04-14       Impact factor: 4.982

Review 5.  The pathobiology of vascular malformations: insights from human and model organism genetics.

Authors:  Sarah E Wetzel-Strong; Matthew R Detter; Douglas A Marchuk
Journal:  J Pathol       Date:  2016-12-04       Impact factor: 7.996

6.  Hypoxic adaptation engages the CBP/CREST-induced coactivator complex of Creb-HIF-1α in transactivating murine neuroblastic glucose transporter.

Authors:  Shanthie Thamotharan; Nupur Raychaudhuri; Masatoshi Tomi; Bo-Chul Shin; Sherin U Devaskar
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-01-15       Impact factor: 4.310

7.  Association study of genetic polymorphisms of SLC2A10 gene and type 2 diabetes in the Taiwanese population.

Authors:  W H Lin; L M Chuang; C H Chen; J I Yeh; P S Hsieh; C H Cheng; Y T Chen
Journal:  Diabetologia       Date:  2006-04-04       Impact factor: 10.122

8.  A novel non-sense mutation in the SLC2A10 gene of an arterial tortuosity syndrome patient of Kurdish origin.

Authors:  Syed H E Zaidi; Sascha Meyer; Vanya D Peltekova; Angelika Lindinger; Ahmad S Teebi; Muhammad Faiyaz-Ul-Haque
Journal:  Eur J Pediatr       Date:  2008-09-26       Impact factor: 3.183

9.  Functional properties and genomics of glucose transporters.

Authors:  Feng-Qi Zhao; Aileen F Keating
Journal:  Curr Genomics       Date:  2007-04       Impact factor: 2.236

10.  Glucose transport in human peripheral blood lymphocytes influenced by type 2 diabetes mellitus.

Authors:  Paweł Piatkiewicz; Anna Czech; Jan Tatoń
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2007-03-20       Impact factor: 4.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.